Fibrinogen and von Willebrand factor and susceptibility vessel sign on T2*-weighted gradient echo imaging

Eur Neurol. 2014;72(5-6):375-7. doi: 10.1159/000365443. Epub 2014 Oct 25.

Abstract

Background: We investigated the relationship between von Willebrand factor (vWF), fibrin monomers (FM), fibrinogen baseline levels and the presence of susceptibility vessel sign (SVS) on T2*-weighted gradient echo imaging in acute ischemic stroke.

Methods: SVS was assessed at admission using T2*-weighted GRE. Plasmatic levels of vWF, FM and fibrinogen were evaluated before the initiation of intravenous thrombolysis.

Results: Forty-four patients were enrolled in this study. SVS was noted in 26 patients. Univariate analysis revealed that vWF >160% (p = 0.02) and fibrinogen >4 g/l (p = 0.03) were associated with a significant decrease in the likelihood of SVS. Multivariate analysis confirmed that higher levels of vWF or fibrinogen predicted the absence of SVS.

Conclusions: The increased activity of vWF may promote a fibrin-platelet recruitment mainly contributing to the absence of (SVS).

MeSH terms

  • Aged
  • Biomarkers / blood
  • Brain Ischemia / blood
  • Brain Ischemia / pathology*
  • Brain Ischemia / therapy
  • Cerebral Angiography
  • Female
  • Fibrin / metabolism*
  • Fibrinogen / metabolism*
  • Humans
  • Magnetic Resonance Angiography
  • Magnetic Resonance Imaging
  • Male
  • Multivariate Analysis
  • Severity of Illness Index
  • Stroke / blood
  • Stroke / pathology*
  • Stroke / therapy
  • Thrombolytic Therapy
  • Treatment Outcome
  • von Willebrand Factor / metabolism*

Substances

  • Biomarkers
  • von Willebrand Factor
  • Fibrin
  • Fibrinogen